How thalidomide works against cancer

Science

Volumn 343, Issue 6168, 2014, Pages 256-257

  Stewart, A Keith ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIOLOS TRANSCRIPTION FACTOR; CEREBLON PROTEIN; CULLIN; CULLIN 4A; DNA BINDING PROTEIN; DNA BINDING PROTEIN 1; IKAROS TRANSCRIPTION FACTOR; IKAROS TRANSCRIPTION FACTOR ZINC FINGER PROTEIN 1; IKAROS TRANSCRIPTION FACTOR ZINC FINGER PROTEIN 3; IMMUNOMODULATING AGENT; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 2; LENALIDOMIDE; MELPHALAN; MYC PROTEIN; POMALIDOMIDE; PROTEASOME INHIBITOR; REGULATOR OF CULLIN 1; THALIDOMIDE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ANTINEOPLASTIC AGENT; CRBN PROTEIN, HUMAN; DRUG DERIVATIVE; IKZF1 PROTEIN, HUMAN; IKZF3 PROTEIN, HUMAN; PEPTIDE HYDROLASE; TERATOGENIC AGENT;

CANCER; HEMATOLOGY;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; CYTOKINE PRODUCTION; DRUG POTENCY; DRUG PROTEIN BINDING; ENZYME REGULATION; GENE EXPRESSION REGULATION; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNE RESPONSE; LEUKEMOGENESIS; MULTIPLE MYELOMA; MYELOMA CELL; NATURAL KILLER CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TERATOGENICITY; METABOLISM; NOTE;

ANTINEOPLASTIC AGENTS; HUMANS; IKAROS TRANSCRIPTION FACTOR; MULTIPLE MYELOMA; PEPTIDE HYDROLASES; TERATOGENS; THALIDOMIDE;

EID: 84892594283     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1249543     Document Type: Review

References (15)

1. G. Lu et al., Science 343, 305 (2014); 10.1126/science.1244917.
2. J. Krönke et al., Science 343, 301 (2014); 10.1126/science.1244851.
3. S. Singhal et al., N. Engl. J. Med. 341, 1565 (1999).
4. A. K. Stewart, P. G. Richardson, J. F. San-Miguel, Blood 114, 5436 (2009).
5. Y. X. Zhu, K. M. Kortuem, A. K. Stewart, Leuk. Lymphoma 54, 683 (2013).
6. T. Ito et al., Science 327, 1345 (2010).
7. Y. X. Zhu et al., Blood 118, 4771 (2011).
8. A. L. Shaffer et al., Nature 454, 226 (2008).
9. L. H. Zhang et al., Br. J. Haematol. 160, 487 (2013).
10. S. R. Schuster et al., Leuk. Res. 38, 23 (2014).
11. B. Morgan et al., EMBO J. 16, 2004 (1997).
12. K. Georgopoulos et al., Cell 79, 143 (1994).
13. M. Cortés, K. Georgopoulos, J. Exp. Med. 199, 209 (2004).
14. C. G. Mullighan et al., Nature 453, 110 (2008).
15. H. Ludwig et al., Blood 119, 3003 (2012).